Cite
Co-delivery of Interleukin-12 and doxorubicin loaded Nano-delivery system for enhanced immunotherapy with polarization toward M1-type Macrophages.
MLA
Li, Tushuai, et al. “Co-Delivery of Interleukin-12 and Doxorubicin Loaded Nano-Delivery System for Enhanced Immunotherapy with Polarization toward M1-Type Macrophages.” European Journal of Pharmaceutics & Biopharmaceutics, vol. 177, Aug. 2022, pp. 175–83. EBSCOhost, https://doi.org/10.1016/j.ejpb.2022.07.002.
APA
Li, T., Liu, Z., Fu, X., Chen, Y., Zhu, S., & Zhang, J. (2022). Co-delivery of Interleukin-12 and doxorubicin loaded Nano-delivery system for enhanced immunotherapy with polarization toward M1-type Macrophages. European Journal of Pharmaceutics & Biopharmaceutics, 177, 175–183. https://doi.org/10.1016/j.ejpb.2022.07.002
Chicago
Li, Tushuai, Zhihong Liu, Xiao Fu, Yongquan Chen, Shenglong Zhu, and Jie Zhang. 2022. “Co-Delivery of Interleukin-12 and Doxorubicin Loaded Nano-Delivery System for Enhanced Immunotherapy with Polarization toward M1-Type Macrophages.” European Journal of Pharmaceutics & Biopharmaceutics 177 (August): 175–83. doi:10.1016/j.ejpb.2022.07.002.